Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001562180-24-008663

Chief Scientific Officer sold 100,000 shares at $27.37 ($2,737,470)

  • Chief Scientific Officer acquired 100,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Russell Alan J · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-12-30 Exercise or conversion : show line 1 in the form 10b5-1 +100,000 $0.18 $18,000 114,863 D
2024-12-30 Sale : show line 2 in the form 10b5-1 −100,000 $27.37 $2,737,470 14,863 D
Open-market sales · 100,000 sh · avg $27.37 · $2,737,470

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-12-30 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −100,000 1,356,780 D
Loading xslF345X05/primarydocument.xml…